Shares with top news: Plug Power, BioNTech, Prospect Ridge

Prospect Ridge Resources: Another promising gold find

For Prospect Ridge Resources Corp., the acquired historical concession areas are turning more and more into real gold mines. The Canadian Company wants to bring them back to life with modern technology, and the plan seems to be working. Prospect Ridge has published positive exploration data several times in the past months. Preliminary results were recently released from the Hugin zone in the recently acquired Knauss Creek concession area. Assays have returned up to 3.49 g/t gold in slots over 0.73 meters. The entire slot averaged 2.4 g/t over 1.54 meters. The Hugin Zone is located only a few kilometers from a direct rail link to the deepwater port at Kitimat. The nearest logging road is only 1.3 km away. In early December, Knauss Creek already reported assay data of up to 57.3 g/t gold and 116 g/t silver, 7.03% lead, 0.5% copper and 2.46% zinc.

Knauss Creek is adjacent to the Holy Grail permit area. Holy Grail is the Prospect Ridge flagship located adjacent to the so-called "Golden Triangle" in western Canada. There are 12 historic mines on the 70,000-hectare property. Rocks have already been found on the property where gold can be seen with the naked eye. In addition, Holy Grail offers world-class infrastructure, including two highways, rail lines, power lines, and forest roads. In late November, exploration work revealed 117 g/t gold and 578 g/t silver. Furthermore, the property also has indications of other metals, such as copper, molybdenum and even lithium. With a market capitalization of around CAD 34 million, Prospect Ridge does not appear to be too highly valued. The share is now also traded in Germany. However, orders should only be placed with a limit. With a bit of patience, the share could become a goldmine for investors in the medium term.

BioNTech: New order from Germany soon?

After the vaccination campaign for 5 to 11 year olds, there is again positive news about BioNTech. A preliminary evaluation in South Africa has shown that the COVID-19 vaccine from the Mainz-based Company prevents "only" 33% of infections in Omicron but protects 70% against severe disease. The data refers to a double vaccination. The booster should, therefore, further improve the efficacy. The analysis was based on around 211,000 positive test results, of which about 78,000 were found to contain the Omicron variant. In addition, BioNTech should soon benefit from new orders. Health Minister Karl Lauterbach announced Wednesday that the Company's vaccine inventory was insufficient for the booster campaign. He also said that the quantities already ordered for the first quarter of 2022 were too low. Accordingly, demand for the BioNTech vaccine is likely to remain high, especially since booster vaccinations are also in full swing in the United Kingdom, where Omicron is expected to become the predominant variant as early as this week.

Plug Power enters into cooperation in the USA

The Plug Power share has recently corrected significantly. Within four weeks, the share price fell from EUR 39 to EUR 26. However, the hydrogen specialist from the United States seems to be doing well operationally. A partnership in the home market USA was recently reported. With the transport Company Certarus, Plug Power wants to expand its local delivery capacities further. Certarus is a leader in North America in the transportation of compressed natural gas. Plug Power's customers will be supplied with green hydrogen via this established logistics platform with a fleet of compressed natural gas trailers. Deliveries of up to 10 tons per day are scheduled to begin as early as the first quarter of next year. Plug Power is thus taking another step toward meeting its medium-term goals. By 2028, up to 1,000 tons of green hydrogen will be delivered to customers worldwide every day.

When the stock market environment stabilizes, positive corporate news will again come into focus. The BioNTech share will continue to be driven by the development of the Corona pandemic, even though the Company is working hard on research in the cancer area. Prospect Ridge is still largely unknown. But if positive results continue to be reported, that could change quickly. Plug Power underpins its leading position in the hydrogen sector with its cooperation with Certarus.